BCIQ Profiles

Company Profile Report
1013 Chord
BioCentury & Getty Images

Finance

Chord launches with $16M to test MS drug cladribine in rare autoimmune disorders

Omega Funds is sole investor for Swiss start-up’s series A, reuniting firm with CEO Plitz 

Chord Therapeutics’ series A round reunites Omega Funds with the Swiss start-up’s CEO, Tom Plitz, the former CSO

Read the full 492 word article

How to gain access

Continue reading with a
two-week free trial.